Hawaii Society of Clinical Oncology (HSCO) 2022 Annual Conference - Saturday, November 5th

Target Audience

Physicians, Pharmacists, Physician Assistants, Nurses, and Nurse Practitioners who are interested in the field of Oncology

Learning Objectives

At the end of this educational activity, participants should be able to:

1.    Summarize recent clinical trial findings related to various cancers, including breast cancer, liver cancer, blood cancers, and pediatric cancers. 

2.    Use new knowledge about CAR T-cell therapy and other immunotherapies to inform decisions related to the treatment of some cancers.

3.    Describe how next-generation sequencing enables more precise care for patients.

4.    Provide patients who are seeking more holistic care with information on integrative oncology.

5.    Apply strategies that can help them better manage and assess the literature. 

6.    Detail state and federal policies affecting the practice of oncology. 

Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 5.50 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 3.25 ANCC Pharmacology
  • 5.50 Participation
Course opens: 
11/05/2022
Course expires: 
11/05/2023
Rating: 
5

CME Program Manager: Naomi Moeller

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Hawaii Society of Clinical Oncology.

Boston University School of Medicine designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the Hawaii Society of Clinical Oncology.

Contact Hours: 5.50, of which 3.25 is pharmacology credit worthy

 

Available Credit

  • 5.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 5.50 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
    • 3.25 ANCC Pharmacology
  • 5.50 Participation
Please login or register to take this course.